Resolving inter- and intra-patient heterogeneity in NPM1-mutated AML at single-cell resolution
Karakaslar, E. O.; Argiro, E. M.; Struckman, N. E.; Shirali, R. H.; Severens, J. F.; Honders, W. M.; Kloet, S. L.; Veelken, H.; Reinders, M. J.; Griffioen, M.; van den Akker, E. B.
Show abstract
NPM1-mutated AML is one of the largest entities in international classification systems of myeloid neoplasms, which are based on integrating morphologic and clinical data with genomic data. Previous research, however, indicates that bulk transcriptomics-based subtyping may improve prognostication and therapy guidance. Here, we characterized the heterogeneity in NPM1-mutated AML by performing single-cell RNA-sequencing and spectral flow cytometry on 16 AML belonging to three distinct subtypes previously identified by bulk transcriptomics. Using single-cell expression profiling we generated a comprehensive atlas of NPM1-mutated AML, collectively reconstituting complete myelopoiesis. The three NPM1-mutated transcriptional subtypes showed consistent differences in the proportions of myeloid cell clusters with distinct patterns in lineage commitment and maturational arrest. In all samples, malignant cells were detected across different myeloid cell clusters, indicating that NPM1-mutated AML are heavily skewed but not fully arrested in myelopoiesis. Same-sample multi-color spectral flow cytometry recapitulated these skewing patterns, indicating that the three NPM1-mutated subtypes can be consistently identified across platforms. Moreover, our analyses highlighted differences in the abundance of rare hematopoietic stem cells suggesting that skewing occurs early in myelopoiesis. To conclude, by harnessing single-cell RNA-sequencing and spectral flow cytometry, we provide a detailed description of three distinct and reproducible patterns in lineage skewing in NPM1-mutated AML that may have potential relevance for prognosis and treatment of patients with NPM1-mutated AML. KEY MESSAGESO_LINPM1-mutated AML shows strong intra- and interpatient heterogeneity with malignant cells skewed rather than fully arrested at different maturation stages in myelopoiesis. C_LIO_LISingle-cell RNA sequencing and spectral flow cytometry revealed recurrent patterns in proportions of malignant myeloid cells with distinct patterns in lineage commitment and maturational arrest. C_LI GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=91 SRC="FIGDIR/small/24317471v1_ufig1.gif" ALT="Figure 1"> View larger version (23K): org.highwire.dtl.DTLVardef@bec2org.highwire.dtl.DTLVardef@ebf121org.highwire.dtl.DTLVardef@23d1e7org.highwire.dtl.DTLVardef@1a9ab54_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Acute myeloid leukemia stratifies as two clinically relevant sphingolipidomic subtypes 98%
- Single cell long-read genotyping of transcriptomes reveals discrete mechanisms of clonal evolution in post-myeloproliferative neoplasm acute myeloid leukemia. 95%
- Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities 95%
Similar papers in this journal
- Disruption of a GATA2, TAL1, ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells 96%
- Leukemia escapes immunity by imposing a Type-1 regulatory program on neoantigen-specific CD4+ T cells. 96%
- A JAK/STAT-Mediated Inflammatory Signaling Cascade Drives Oncogenesis In AF10-Rearranged AML 96%
Similar papers in this journal
- AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML 98%
- Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties 98%
- Mapping AML heterogeneity – multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses 97%
Similar papers in this journal
- Genome-wide CRISPR Screens Identify Ferroptosis as a Novel Therapeutic Vulnerability in Acute Lymphoblastic Leukemia 95%
- Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia 95%
- ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis 94%
Similar papers in this journal
- Multimodal Spatial Proteomic Profiling in Acute Myeloid Leukemia 97%
- Multimodal classification of molecular subtypes in pediatric acute lymphoblastic leukemia 96%
- Mutated clones driving leukemic transformation are already detectable at the single cell level in CD34-positive cells in the chronic phase of primary myelofibrosis 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.